Proposed Voluntary Delisting
BiVictriX Therapeutics PLC 12 August 2024 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. With the publication of this announcement via a Regulatory Information Service, this inside information is now […]
BiVictriX Therapeutics plc Shares now trading on JP Jenkins
11th Sept 2024 JPJ: BVX ISIN: GB00BNXH3K91 BiVictriX Therapeutics plc (“BiVictriX” or the “Company”) Shares now trading on JP Jenkins London, UK. 11th Sept July 2024 – BiVictriX Therapeutics plc (JPJ: BVX), a drug discovery and development company applying an innovative, proprietary approach to develop a new class of highly selective, next generation cancer therapeutics, bispecific […]